Symptom Alleviation/Resolution and Returns to Usual Health/Activities in Immunocompromised Adults with COVID-19 Treated with Nirmatrelvir-Ritonavir: Results from the EPIC-IC Trial.
Saved in:
| Title: | Symptom Alleviation/Resolution and Returns to Usual Health/Activities in Immunocompromised Adults with COVID-19 Treated with Nirmatrelvir-Ritonavir: Results from the EPIC-IC Trial. |
|---|---|
| Authors: | Mokgokong, Ruth1 (AUTHOR) ruth.mokgokong@pfizer.com, Cislo, Paul2 (AUTHOR), Tudone, Elena3 (AUTHOR), Weinstein, Edward2 (AUTHOR), Cappelleri, Joseph C.4 (AUTHOR) |
| Source: | Infectious Diseases & Therapy. Dec2025, Vol. 14 Issue 12, p2763-2783. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
